LifeScan Inc., a Johnson & Johnson company, has initiated a voluntary recall and replacement of its OneTouch VerioIQ blood glucose meters in the U.S., effective immediately.
The recall stems from the fact that the OneTouch VerioIQ blood glucose meter does not provide an appropriate warning at glucose levels of 1024 mg/dL or higher, and gets shut off.
Although the probability of experiencing an extremely high blood glucose level of 1024 mg/dL or higher is remote, such a condition requires immediate medical attention. If diagnosis and treatment of extreme hyperglycemia is delayed, it may result in potentially serious health risk or fatality, the company said.
Patients who are using the OneTouch VerioIQ Meter are requested to contact LifeScan Customer Service at (800) 717-0276 to make arrangements to receive a replacement meter at no charge and to speak with a LifeScan representative.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.